TNGX NASDAQ
Tango Therapeutics, Inc.
1W: +33.9%
1M: +31.7%
3M: +88.0%
YTD: +246.4%
1Y: +781.2%
3Y: +1058.4%
5Y: +180.4%
$31.56
+0.63 (+2.04%)
Weekly Expected Move ±13.7%
$15
$17
$20
$23
$26
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026223
Institutions Holding
+28 vs prior
90.6%
Ownership
+49.27%
53
New
57
Increased
99
Reduced
52
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-05 | Ketchum John B | director | A-Grant/Award | 4,000 | $— | $0 | Filing |
| 2026-06-05 | Rothenberg Mace | director | A-Grant/Award | 4,000 | $— | $0 | Filing |
| 2026-06-05 | Calhoun Lesley Ann | director | A-Grant/Award | 4,000 | $— | $0 | Filing |
| 2026-06-05 | Lee Sung | director | A-Grant/Award | 570 | $— | $0 | Filing |
| 2026-06-01 | Crystal Adam | officer: president, r&d | S-Sale | 20,860 | $23.06 | $481K | Filing |
| 2026-06-01 | Crystal Adam | officer: president, r&d | S-Sale | 6,140 | $22.25 | $137K | Filing |
| 2026-05-01 | Gall Matthew | officer: chief financial officer | A-Grant/Award | 40,000 | $— | $0 | Filing |
| 2026-05-01 | Crystal Adam | officer: president, r&d | S-Sale | 1,100 | $22.00 | $24K | Filing |
| 2026-05-01 | Crystal Adam | officer: president, r&d | S-Sale | 25,900 | $21.19 | $549K | Filing |
| 2026-04-29 | Lee Sung | director | A-Grant/Award | 12,300 | $— | $0 | Filing |
| 2026-04-15 | Crystal Adam | officer: president, r&d | S-Sale | 38,460 | $25.00 | $962K | Filing |
| 2026-04-01 | Crystal Adam | officer: president, r&d | S-Sale | 27,000 | $21.20 | $572K | Filing |
| 2026-03-25 | Crystal Adam | officer: president, r&d | S-Sale | 12,000 | $20.11 | $241K | Filing |
| 2026-02-25 | Crystal Adam | officer: president, r&d | S-Sale | 54,345 | $12.77 | $694K | Filing |
| 2026-02-03 | Beckman Daniella | officer: chief financial officer | S-Sale | 113 | $12.90 | $1K | Filing |
| 2026-02-03 | Weber Barbara | officer: director, executive chair | S-Sale | 333 | $12.90 | $4K | Filing |
| 2026-02-03 | Weber Barbara | officer: director, executive chair | S-Sale | 30,186 | $12.26 | $370K | Filing |
| 2026-02-03 | Crystal Adam | officer: president, r&d | S-Sale | 201 | $12.90 | $3K | Filing |
| 2026-02-03 | Crystal Adam | officer: president, r&d | S-Sale | 18,251 | $12.26 | $224K | Filing |
| 2026-02-03 | Beckman Daniella | officer: chief financial officer | S-Sale | 10,204 | $12.26 | $125K | Filing |
| 2026-02-02 | Weber Barbara | officer: director, executive chair | A-Grant/Award | 37,522 | $— | $0 | Filing |
| 2026-02-02 | Crystal Adam | officer: president, r&d | A-Grant/Award | 47,460 | $— | $0 | Filing |
| 2026-02-02 | Beckman Daniella | officer: chief financial officer | A-Grant/Award | 44,330 | $— | $0 | Filing |
| 2026-01-08 | Peters Malte | officer: president & ceo | A-Grant/Award | 350,000 | $— | $0 | Filing |
| 2026-01-02 | Lee Sung | director | A-Grant/Award | 10,000 | $— | $0 | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 13,300,620 | $278M | +11,809,392 | 2026-03-31 | Filing |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 12,809,485 | $268M | +2,201,561 | 2026-03-31 | Filing |
| Boxer Capital Management, LLC | 10,876,219 | $228M | — | 2026-03-31 | Filing |
| TCG Crossover Management, LLC | 10,531,071 | $220M | -2,231,023 | 2026-03-31 | Filing |
| FMR LLC | 9,905,919 | $207M | +7,038,371 | 2026-03-31 | Filing |
| FARALLON CAPITAL MANAGEMENT LLC | 9,097,411 | $190M | -3,964,000 | 2026-03-31 | Filing |
| BlackRock, Inc. | 8,748,045 | $183M | +207,248 | 2026-03-31 | Filing |
| Woodline Partners LP | 8,000,013 | $167M | -2,072,212 | 2026-03-31 | Filing |
| TRV GP IV, LLC | 6,374,574 | $133M | -1,500,000 | 2026-03-31 | Filing |
| Siren, L.L.C. | 5,657,105 | $118M | -2,508,269 | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,161,431 | $108M | +5,161,431 | 2026-03-31 | Filing |
| GOLDMAN SACHS GROUP INC | 5,076,392 | $106M | +133,978 | 2026-03-31 | Filing |
| STATE STREET CORP | 4,651,894 | $97M | -1,566,673 | 2026-03-31 | Filing |
| Paradigm Biocapital Advisors LP | 4,009,679 | $84M | +4,009,679 | 2026-03-31 | Filing |
| Holocene Advisors, LP | 3,932,603 | $82M | +3,932,603 | 2026-03-31 | Filing |
| Balyasny Asset Management L.P. | 3,826,659 | $80M | -1,451,921 | 2026-03-31 | Filing |
| Logos Global Management LP | 3,000,000 | $63M | -1,200,000 | 2026-03-31 | Filing |
| Deep Track Capital, LP | 2,750,000 | $58M | +295,438 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2,675,777 | $56M | +122,121 | 2026-03-31 | Filing |
| Caligan Partners LP | 2,408,798 | $50M | -1,321,097 | 2026-03-31 | Filing |